Brainsway stock sale pulls in about $67.6M

10/7/2013 | Globes (Israel)

Brainsway, maker of the Deep Transcranial Magnetic Stimulation, or TMS, device designed to treat depression, has secured about $6.76 million in a shares offering in Israel. Over the weekend, the company also obtained $1 million in initial payments from a Japanese distributor that agreed to market its depression systems.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC